News


PHORMED ACQUIRES 5 PATENTS FROM PROFESSOR RICHARD L CHANG

On August 1, 2019, PhorMed entered into multiple contracts to acquire five of Professor Ricard L. Chang’s patent inventions. These contracts cover patent assignments for the use of his compound, RP-323, in the treatment of Acute Myeloid Leukemia, Hodgkin’s Lymphoma, Parkinson’s disease, Stroke, and a new patent for treating platelets. The company’s goals for these technologies are to develop first line treatments and create a new class of drug for neurological diseases.

« Return to News